Why the study?
Does radiofrequency ablation of ventricular tachycardia reduce the frequency of ICD therapies in patients with coronary artery disease and an ICD experiencing frequent therapies despite antiarrhythmic drugs?
Population
21 consecutive patients with coronary artery disease, an implantable cardioverter-defibrillator, and…
Design
Cohort
Follow-up
11.8+/-10.0 months
Authors
Loading...
May support ablation to reduce ICD therapies in refractory CAD cases; leaves open need for randomized confirmation.
Does radiofrequency ablation of ventricular tachycardia reduce the frequency of ICD therapies in patients with coronary artery disease and an ICD experiencing frequent therapies despite antiarrhythmic drugs?
Radiofrequency ablation of ventricular tachycardia significantly reduces the frequency of ICD therapies and improves quality of life in patients with coronary artery disease and frequent ICD therapies despite antiarrhythmic drugs.
Strickberger et al. (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: